Provided by Tiger Trade Technology Pte. Ltd.

Mizuho

10.64
0.0000
Post-market: 10.690.0500+0.47%19:30 EDT
Volume:2.77M
Turnover:29.59M
Market Cap:129.73B
PE:15.44
High:10.80
Open:10.77
Low:10.63
Close:10.64
52wk High:11.06
52wk Low:6.09
Shares:12.19B
Float Shares:11.07B
Volume Ratio:1.16
T/O Rate:0.03%
Dividend:0.18
Dividend Rate:1.71%
EPS(TTM):0.6892
EPS(LYR):0.6326
ROE:12.49%
ROA:0.48%
PB:1.80
PE(LYR):16.82

Loading ...

Mizuho Financial Gr Q1 EPS $0.22 Up From $0.15 YoY, Sales $15.818B Up From $14.736B YoY

Benzinga Earnings
·
Jul 30

Mizuho Financial Group Doubles Share Buyback Program to 200 Billion Yen

MT Newswires Live
·
Jul 30

Mizuho Financial Group's Profit Soars 46% in Fiscal Q1

MT Newswires Live
·
Jul 30

Mizuho Leasing Injects ¥1.08 Billion Into Restricted Stock Benefit Trust

TIPRANKS
·
Jul 30

Mizuho Leasing Delivers Profit Surge in First Quarter, Confirms Full-Year Outlook and Dividend Plan

TIPRANKS
·
Jul 30

Mizuho Doubles Share Buyback to ¥200 Billion and Extends Cancellation Timeline

TIPRANKS
·
Jul 30

Mizuho lifts full-year profit outlook after robust Q1 earnings

TIPRANKS
·
Jul 30

Mizuho Leasing 1Q Net Y23.26b vs Net Y15.22b

Dow Jones
·
Jul 30

Skyworks is Maintained at Underperform by Mizuho

Dow Jones
·
Jul 30

Coupang is Maintained at Neutral by Mizuho

Dow Jones
·
Jul 29

Brown & Brown is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 29

Mizuho Securities Adjusts CMS Energy Price Target to $77 From $78, Maintains Neutral Rating

MT Newswires Live
·
Jul 29

Mizuho Securities Adjusts NXP Semiconductors Price Target to $190 From $200, Maintains Underperform Rating

MT Newswires Live
·
Jul 29

Mizuho Raises Price Target on EyePoint Pharmaceuticals to $39 From $36, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 29

Mizuho Securities Upgrades Lineage to Outperform From Neutral, Raises Price Target to $47 From $40

MT Newswires Live
·
Jul 29

Mizuho Adjusts Price Target on Xylem to $130 From $124, Maintains Neutral Rating

MT Newswires Live
·
Jul 29

Mizuho Leasing Reviews Impact After Quake Damage at Aeon Mall Kumamoto

TIPRANKS
·
Jul 29

Lineage upgraded to Outperform from Neutral at Mizuho

TIPRANKS
·
Jul 29

Mizuho Securities Sticks to Its Buy Rating for MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jul 29